Contact
Experience and Efficacy of Digital Therapeutics in Major Depression
Data scientist in Basel
3347
portfolio_page-template-default,single,single-portfolio_page,postid-3347,bridge-core-3.1.8,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode-title-hidden,qode_grid_1300,side_area_uncovered_from_content,overlapping_content,qode-content-sidebar-responsive,qode-theme-ver-30.5,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,qode-portfolio-single-template-4,wpb-js-composer js-comp-ver-7.6,vc_responsive

Topic

Major Depression

How do people who have depression use and experience a digital health app

Setup

AU

Part of Rewoso’s real-world-evidence insights projects

Design

R

Realized in R-Statistics, RMarkdown

Studying Experiences and the Efficacy of a Digital Therapeutics in Major Depression

Real-world digital health insights about the user behavior and efficacy of a smartphone application that offers cognitive-behavioral therapy to help people diagnosed with major depression.

This project used real-world data and combined them with digital health device data, investigating the symptom development of patients who are diagnosed with depression and who were newly-prescribed a clinically-approved digital health application (edupression.com(R)). The results looked promising and aligned with the results that a phase-III randomized clinical trial has found about edupression.com(R), and details will be forthcoming at the 2024 DGN congress.

You can read the abstract if it is published at the DGN Congress.